Article Text

Download PDFPDF
Consumer surplus and cost-benefit analysis of tobacco use in countries in the earlier stages of the tobacco epidemic
  1. Hana Ross1,2
  1. 1University of Cape Town, SALDRU, Cape Town, South Africa
  2. 2St Anne's University Hospital, International Clinical Research Center, Brno, Czech Republic
  1. Correspondence to Hana Ross, University of Cape Town, SALDRU, Rondebosch 7700, Cape Town, South Africa;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The paper by Chaloupka et al (2014) represents a very important contribution to the debate about the benefits and costs of tobacco control regulations, not only in the USA, but in the rest of the world.

Cost-benefit analysis (CBA) has been a standard tool for assessing the soundness of government policies in the USA since the 1960s. Since then, many societies have adopted CBA as an important input for decision-making in various domains, including the sphere of public health. For example, the European Commission since 2003 has required Impact Assessments for all proposed regulations that must include quantification of all significant costs and benefits as well as analysis of economic, social and environmental impacts.1

For this reason, it is critical that policy makers understand not only the power, but also the potential pitfalls when applying CBA, especially when applying CBA in contexts that involve less-than-fully rational …

View Full Text


  • Funding This work was supported by the European Regional Development Fund, project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and by the Czech Ministry of Health (NT13434-4/2012).

  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles